Teva Parenteral Medicines, a wholly owned subsidiary of Teva Pharmaceuticals USA, has recalled six lots of Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL), it was reported yesterday.
Its other three medicines are Folex PFS and Neosar, both for treatment alone or in combination with other anticancer drugs; and Adrucil, for symptom management.